Phase4 Ventures

Phase4 Ventures is a venture capital firm based in London that invests in development stage life science companies in the US.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Phase4 Ventures Information

Geographic Data

Phase4 Ventures headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Phase4 Ventures is a venture capital firm based in London that invests in development stage life science companies in the US and Europe. Founded in 1999, the team has made close to 30 investments in Life Science companies alongside other top tier venture capital firms in both Europe and the US. The team is complemented by an extensive group of advisors with operating experience at a senior level in pharmaceutical and biotechnology companies. Phase4 Ventures&s; investments include many of the companies that have provided successful European and US venture exits including Intercell, Pharmion, Targacept and most recently Proteolix. Phase4 Ventures was spun-out from Nomura in December 2010 following a buy out of the management company by the team and a secondary purchase of a fund by HarbourVest Partners. Phase4 Ventures currently manages funds for both Nomura and HarbourVest. Phase4 Ventures Limited is a member of the British Private Equity and Venture Capital Association (BVCA) and the European Private Equity and Venture Capital Association (EVCA).

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
9/2007 Nabriva Therapeutics Venture Round 56M
5/2004 Altus Pharmaceuticals Series C 0
11/2007 Zosano Pharma Series A 90M
2/2006 ARYx Therapeutics Series E 30.4M
4/2006 Chroma Therapeutics Series C 53M
6/2004 ARYx Therapeutics Series D 55M
9/2008 Proteolix Series C 79M
11/2008 OncoMed Pharmaceuticals Series B 154M
8/2009 Zosano Pharma Series B 30M
3/2007 Phenomix Series C 55M
10/2005 Cerimon Pharmaceuticals Series A 70M
8/2009 Zosano Pharma Series B 0
11/2008 OncoMed Pharmaceuticals Series B 0
9/2008 Proteolix Series C 0
11/2007 Zosano Pharma Series A 0
9/2007 Nabriva Therapeutics Venture Round 0
3/2007 Phenomix Series C 0
4/2006 Chroma Therapeutics Series C 0
2/2006 ARYx Therapeutics Series E 0
10/2005 Cerimon Pharmaceuticals Series A 0
6/2004 ARYx Therapeutics Series D 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research